Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Berruti

Showing results (31-40 of 379) with videos related to

Pageof 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Reversible pancytopenia caused by oral letrozole assumption in a patient with recurrent breast cancerPaola Sperone, Gabriella Gorzegno, Alfredo Berruti, et al.
Tumori|July 14, 2015
Management of patients with castration-resistant prostate cancer (CRPC): results of an Italian survey using the delphi methodCarlo Terrone, Alfredo Berruti, Mauro Papotti, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 17, 2007
Thrombotic thrombocytopenic purpura in advanced prostate cancer: case report and published work reviewValeria Caramello, Andrea Dovio, Pasquale Caraci, et al.
Expert Opinion on Investigational Drugs|July 26, 2014
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumorsAndrea Giustina, Gherardo Mazziotti, Filippo Maffezzoni, et al.
Endocrine|September 24, 2021
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines?Salvatore Grisanti, Deborah Cosentini, Marta Laganà, et al.
Future Oncology (London, England)|June 21, 2014
Testosterone serum levels and prostate cancer prognosis: the double face of JanusFrancesca Valcamonico, Laura Ferrari, Francesca Consoli, et al.
Virchows Archiv : an International Journal of Pathology|February 24, 2011
The pathological diagnosis of neuroendocrine tumors: common questions and tentative answersMarco Volante, Luisella Righi, Alfredo Berruti, et al.
Journal of the National Cancer Institute. Monographs|November 2, 2011
Predictive immunohistochemical biomarkers in the context of neoadjuvant therapy for breast cancerDaniele Generali, William F Symmans, Alfredo Berruti, et al.
Prostate Cancer and Prostatic Diseases|November 23, 2021
Is BMI a reliable prognostic parameter in metastatic prostate cancer patients?Irene Caramella, Alberto Dalla Volta, Francesca Valcamonico, et al.
Cancer|September 5, 2002
Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinomaAlfredo Berruti, Marcello Tucci, Luigi Dogliotti, et al.
Pageof 38

Showing results (31-40 of 379) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Reversible pancytopenia caused by oral letrozole assumption in a patient with recurrent breast cancerPaola Sperone, Gabriella Gorzegno, Alfredo Berruti, et al.
Tumori|July 14, 2015
Management of patients with castration-resistant prostate cancer (CRPC): results of an Italian survey using the delphi methodCarlo Terrone, Alfredo Berruti, Mauro Papotti, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 17, 2007
Thrombotic thrombocytopenic purpura in advanced prostate cancer: case report and published work reviewValeria Caramello, Andrea Dovio, Pasquale Caraci, et al.
Expert Opinion on Investigational Drugs|July 26, 2014
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumorsAndrea Giustina, Gherardo Mazziotti, Filippo Maffezzoni, et al.
Endocrine|September 24, 2021
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines?Salvatore Grisanti, Deborah Cosentini, Marta Laganà, et al.
Future Oncology (London, England)|June 21, 2014
Testosterone serum levels and prostate cancer prognosis: the double face of JanusFrancesca Valcamonico, Laura Ferrari, Francesca Consoli, et al.
Virchows Archiv : an International Journal of Pathology|February 24, 2011
The pathological diagnosis of neuroendocrine tumors: common questions and tentative answersMarco Volante, Luisella Righi, Alfredo Berruti, et al.
Journal of the National Cancer Institute. Monographs|November 2, 2011
Predictive immunohistochemical biomarkers in the context of neoadjuvant therapy for breast cancerDaniele Generali, William F Symmans, Alfredo Berruti, et al.
Prostate Cancer and Prostatic Diseases|November 23, 2021
Is BMI a reliable prognostic parameter in metastatic prostate cancer patients?Irene Caramella, Alberto Dalla Volta, Francesca Valcamonico, et al.
Cancer|September 5, 2002
Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinomaAlfredo Berruti, Marcello Tucci, Luigi Dogliotti, et al.
Pageof 38